Skip to main content
logo
enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
6.73
-0.29 (-4.13%)
Oct 30, 2026, 4:00 PM EDT - Market closed

enVVeno Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-16.74-20.9-23.83-25.24-24.93-16.89
Net Income
-15.55-19.47-21.82-23.52-24.67-16.53
Earnings Per Share
-23.54-33.06-44.53-66.91-91.15-66.65
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18.4728.2143.1546.4139.0454.73
Total Debt
0.410.71.061.41.722.01
Net Cash (Debt)
18.0627.5142.0945.0137.3352.72
Net Cash Growth
-40.11%-34.63%-6.49%20.58%-29.20%523.64%
Net Cash Per Share
27.3446.7185.90128.07137.93212.59

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.41-15.57-16.84-18.86-15.62-11.85
Capital Expenditures
--0.01-0.04-0.03-0.12-0.37
Free Cash Flow
-13.41-15.57-16.88-18.89-15.73-12.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------